BMCS Financials 07/16/2014 07:28:19 BioTech Medic
Post# of 51
Posted On: 07/16/2014 8:28:16 AM
BMCS Financials 07/16/2014 07:28:19
BioTech Medics, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue 470 -
Cost of Revenue 45 -
Gross Profit 425 -
Operating Expenses
Research and Development - -
Sales, General and Admin. 348 -
Non-Recurring Items 56 -
Other 617 -
Operating Income (595) -
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (595) -
Interest Expense - -
Earnings Before Tax (595) -
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (595) -
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (604) -
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (604) -
BioTech Medics, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue 470 -
Cost of Revenue 45 -
Gross Profit 425 -
Operating Expenses
Research and Development - -
Sales, General and Admin. 348 -
Non-Recurring Items 56 -
Other 617 -
Operating Income (595) -
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (595) -
Interest Expense - -
Earnings Before Tax (595) -
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (595) -
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (604) -
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (604) -
(0)
(0)Biotech Medics Ne (BMCS) Stock Research Links
Scroll down for more posts ▼